Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5430_Библиотеки_им_академика_М_И_Перельмана
.pdf
74
Metals in Medicine, Volume 2
86.
Cell-Based Cancer Immunotherapy. Nat. Nanotechnol. 2011, 6 (10), 675–682.
87.
J. Colloid Interface Sci. 2013, 399, 19–25.
88.
Chem. Mater. 2010, 22
(11), 3383–3388.
89.
Delivery Response. Acta Biomaterialia. 2010, 6 (7), 2732–2739.
90.
J. Nanosci. Nanotechnol.
2008, 8 (1), 410–415.
91.
DNA Delivery and Bioimaging. Biomaterials 2010, 31 (11), 3087–3094.
92.
J. Am. Chem. Soc. 2008, 130 (24), 7522–7523.
93.
Mater.
Sci. Eng.: C. 2017, 79, 465–472.
94.
Nanoparticles as Adjuvant to Facilitate Doxorubicin Intracellular Accumulation and
Mol. Pharmaceutics
2016, 13 (5), 1723–1730.
95.
Langmuir 2011, 27 (7), 4020–4028.
96.
Small
2006, 2 (5), 621–625.
97.
J. Mater.
Chem. 2012, 22 (45), 24145–24154.
98.
J. Mater. Chem. B. 2015, 3 (26), 5249–5260.
99.
Angew. Chem. Int. Ed. 2015, 54 (2), 536–540.
100.
Potency Using an Acid-Responsive ZnO-incorporated Liposomal Drug-Delivery
System. Nanoscale 2015, 7 (9), 4088–4096.
https://t.me/med1917
Zinc Oxide Nanoformulations for Cancer Therapy
75
101.
Anti-Cancer Drugs. J. Mater. Chem. B. 2014, 2 (25), 3956–3964.
102.
Phys. Chem. Chem. Phys.
2015, 17 (33), 21576–21582.
103.
Antibacterial Potential. Materials. 2020, 13 (19), 4347.
104.
Pharmaceutics.
2019, 11 (10), 493.
105.
Drug Discov.
Today. 2017, 22 (12), 1825–1834.
106. Nat.
Rev. Cancer 2017, 17 (10), 577–593.
107.
Relating Cytotoxicity, Zinc Ions, and Reactive Oxygen in ZnO Nanoparticle–Exposed
Human Immune Cells. Toxicol. Sci. 2013, 136 (1), 120–130.
108.
Nanoscale 2019, 11 (10), 4591–4600.
109.
Nanoparticles on Human Lymphocytes, Dendritic Cells and Exosome Production.
T oxicol. Appl. Pharmacol. 2012, 264 (1), 94–103.
110.
Aging (albany NY). 2020, 12
(24), 25767.
111.
and its Application on Coating. Nanoscale Res. Lett. 2016, 11, 1–9.
112.
BMC Microbiol. 2021, 21 (1), 1–8.
113.
Angewandte Chemie. 2013, 125 (15), 4221–4225.
114.
Toxicol. Rep. 2018, 5, 468–479.
115.
Nano-Metal (oxide) and Polydopamine. Nanotechnology. 2022, 33 (15), 155702.
https://t.me/med1917
76
Metals in Medicine, Volume 2
116.
Genes
2017, 8 (10), 281.
117.
Cells (HepG2). Apoptosis 2012, 17, 852–870.
118.
Zinc Oxide Nanoparticles Against Co-Cultured C2C12 Myoblastoma Cancer and
Biol. Trace Elem. Res. 2016, 172, 148–154.
119.
Nanoparticles Induce Apoptosis and Autophagy in Human Ovarian Cancer Cells. Int. J.
Nanomed. 2017, 12,
120.
Apoptotic Cell Death. Free Radical Biology and Medicine 2017, 110, 42–53.
121.
Nanomedicine 2016, 11 (17), 2239–2242.
122.
Artif. Cells, Nanomed. Biotechnol. 2017,
45 (8), 1769–1777.
123.
Cancer Nanotechnol. 2017, 8 (1), 1–62.
124.
Nanoscale 2017, 9 (40), 15371–15378.
125.
Mater. Lett. 2007, 61 (16),
3416–3420.
126.
Nanocomposite in a549 Lung Adenocarcinomas. Biointerface Res. Appl. Chem. 2022,
12, 1856–1869.
127.
Macrophages Require PI3K Mediated MAPKs Signaling. Toxicology in Vitro. 2014, 28
(3), 457–467.
128.
Nanomaterials Cause Cytotoxicity and Activation on Mouse Antigen Presenting Cells.
Toxicology 2010, 267 (1–3), 125–131.
129.
J. Biomed.
Nanotechnol. 2008, 4 (4), 432–438.
https://t.me/med1917
Zinc Oxide Nanoformulations for Cancer Therapy
77
130.
J. Photochem. Photobiol. 2008, 93 (3), 119–126.
131.
Mol. Pharmaceutics
2005, 2 (3), 194–205.
132.
Chlorotoxin-Conjugated Iron Oxide Nanoparticles. Nanomedicine (Lond). 2008, 3 (4),
133.
Crystals 2021, 11 (4), 344.
134.
Molecules 2022, 27 (6), 1827.
135.
Nanoscale 2019, 11 (27), 12858–12870.
136.
Nanoparticles. Nanoscale 2019, 11 (24), 11789–11807.
137.
Int. J. Mol. Sci. 2017, 18 (3), 656.
138.
Plants. Phytother. Res. 2017, 31 (2), 202–264.
139.
J. Clin. Oncol. 2002, 20 (18 Suppl),
47S–59S.
140.
Anti-Cancer Drugs. 2009, 20 (9),
757–769.
141.
Oxide Nanocomposite. OncoTargets and Therapy. 2016, 4549–4559.
142.
Advancements. J. Mol. Liq. 2021, 331, 115805.
https://t.me/med1917
78
Metals in Medicine, Volume 2
143.
Cancer
Nanotechnol. 2013, 4, 137–143.
144.
Silver Nanoparticles (4-in-1 system). Theranostics 2014, 4 (3), 316.
145.
Mater. Sci. Eng.: C. 2019, 100, 129–140.
146.
Biomedical Applications. Biomed. Pharmacother. 2016, 84, 1213–1222.
147.
Bio. Nano. Sci. 2017, 7 (3), 530–545.
148.
Cytotoxic and Antioxidant Activity. J. Trace Elem. Med. Biol. 2017, 39, 116–123.
149.
Artif. Cells, Nanomed.
Biotechnol. 2018, 46 (5), 968–979.
150.
Enzyme
Microb. Technol. 2018, 117, 91–95.
151.
Human Osteosarcoma Cell Lines. Environ. Sci. Poll. Res. 2018, 25, 10482–10492.
152.
Adv. Nat.
Sci.: Nanosci. Nanotechnol. 2018, 9 (1), 015008.
153.
Photocatalytic Activities. Mater. Sci. Eng.: C. 2018, 82, 46–59.
154.
Cancer Cells. J. Photochem. Photobiol. B: Biol. 2020, 202, 111698.
155.
https://t.me/med1917
Zinc Oxide Nanoformulations for Cancer Therapy
79
Green Synthesis. Karbala Int. J. Mod. Sci. 2015, 1 (2), 67–77.
156.
Spectrochim. Acta A: Mol. Biomol.
Spectrosc. 2015, 137, 250–258.
157.
Zinc Oxide Nanoparticles Against Clinically Important Pathogenic Bacteria, Fungi and
MCF-7 Breast Cancer Cells. Microb. Pathog. 2017, 104, 268–277.
158.
and Anticancer Activity. Mater. Sci. Eng.: C. 2019, 97, 842–850.
159.
Extraction. Cancer Nanotechnol. 2018, 9, 1–6.
160.
Macro-Algae (Gracilaria edulis) Extracts and its Anticancer Activity Against Human
PC3 Cell Lines. Appl. Biochem. Biotechnol. 2014, 174, 2777–2790.
https://t.me/med1917
https://t.me/med1917
Metals in Medicine, Volume 2: Metallic Nanoparticles for Biomedical Applications.
Sonali Sundram, Rishabha Malviya, and GSN Koteswara Rao
© 2025 Apple Academic Press, Inc. Co-published with CRC Press (Taylor & Francis)
Zinc Oxide Nanoparticles in Disease
Diagnosis
ANUSHKA AGRAWAL
1
, VERONICA A.
1
, MYTHREYI R
1
, GOPENATH T. S.
2
,
KANTHESH M. BASALINGAPPA
1
, and GOBIANAND K.
3
1
Division of Molecular Biology, School of Life Sciences, JSS Academy of
Higher Education & Research, Mysuru, Karnataka, India
2
Department of Biotechnology and Bioinformatics, JSS Academy of
Higher Education & Research, Mysuru, Karnataka, India
3
Department of Microbiology, Noorul Islam College of Dental Sciences,
Aralummoodu, Thiruvananthapuram, India
CHAPTER 3
ABSTRACT
-
-
diseases and disorders, including cancer and neurodegenerative diseases as
-
makes counseling and treatments challenging, and this is the primary cause
https://t.me/med1917
82
Metals in Medicine, Volume 2
-
-
tant micronutrients because it regulates many physiological processes and is
-
tive oxygen species (ROS) have been linked to a human neurodegenerative
-
3.1 INTRODUCTION
-
-
-
-
https://t.me/med1917
Zinc Oxide Nanoparticles in Disease Diagnosis
83
-
1
-
chemistry, biology, physics, electronics, biomedical research, and materials
science. NPs can have ligands, such as proteins, antibodies, and nucleic acids
2
dominant procedures, may eventually be surpassed by nanoparticle-based
to interact almost one-on-one.
3
has been increased thanks to several nanoparticles introduced by nanotech-
-
4
Materials at the nano scale range exhibit unique physicochemical
hydrophobic nature, physical appearance (shape or morphology), and aggre-
cancer diagnosis, cell imaging, and tissue engineering.
5
bilayer and being used to deliver drugs and polymeric nanoparticles that are
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана